The effect of activity-based financing on hospital length of stay for elderly patients suffering from heart diseases in Norway by Yin, Jun et al.
RESEARCH ARTICLE Open Access
The effect of activity-based financing on hospital
length of stay for elderly patients suffering from
heart diseases in Norway
Jun Yin1,2*, Hilde Lurås1,3, Terje P Hagen2 and Fredrik A Dahl1
Abstract
Background: Whether activity-based financing of hospitals creates incentives to treat more patients and to reduce the
length of each hospital stay is an empirical question that needs investigation. This paper examines how the level of the
activity-based component in the financing system of Norwegian hospitals influences the average length of hospital stays
for elderly patients suffering from ischemic heart diseases. During the study period, the activity-based component
changed several times due to political decisions at the national level.
Methods: The repeated cross-section data were extracted from the Norwegian Patient Register in the period from 2000
to 2007, and included patients with angina pectoris, congestive heart failure, and myocardial infarction. Data were
analysed with a log-linear regression model at the individual level.
Results: The results show a significant, negative association between the level of activity-based financing and length of
hospital stays for elderly patients who were suffering from ischemic heart diseases. The effect is small, but an increase of
10 percentage points in the activity-based component reduced the average length of each hospital stay by 1.28%.
Conclusions: In a combined financing system such as the one prevailing in Norway, hospitals appear to respond to
economic incentives, but the effect of their responses on inpatient cost is relatively meagre. Our results indicate that
hospitals still need to discuss guidelines for reducing hospitalisation costs and for increasing hospital activity in terms of
number of patients and efficiency.
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Background
Whether the activity-based financing of hospitals pro-
vides staff with incentives to reduce the length of each
hospital stay is an empirical question that needs investi-
gation. In this paper, we analyse how the activity-based
component of a hospital’s financing system influences
the average length of hospital stays (LOS) for elderly pa-
tients suffering from ischemic heart diseases in Norway.
Studies that evaluate the effects of introducing pro-
spective financing systems that are based on the DRG
system in US hospitals during the 1980s indicated a sig-
nificant reduction in LOS in the range of −3 to −9%
[1-10]. The results of European research are divergent,
but most EU studies indicate that introducing a prospect-
ive payment system ultimately engenders negative effects
on LOS, such as −24% in Hungary [11] and −4.6% in
Austria [12]. All of the studies that are listed in this
section have analysed the effects of fundamental system
changes. In contrast, we concentrate our analysis on
the effects of incremental changes in the activity-based
component. The hospitals in many countries are likely
to find our focus to be relevant, because many coun-
tries have implemented systems that combine activity-
based financing in the DRG system with a component
based on fixed payments.
Chalkley and Malcomson already delineated a theoret-
ical understanding of changes in the financing system for
non-profit hospitals [13,14], and Biørn et al. adapted this
theory to the Norwegian setting [15,16]. These models
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often assume a trade-off between efficiency and quality
in hospital production that can be shifted by various
reimbursement systems. Low-powered financing systems,
i.e., reimbursement systems with weak economic incen-
tives, can give rise to serious inefficiencies in the hos-
pital system, yet the public’s perception of the system’s
healthcare services can meanwhile improve. High-powered
prospective payment systems, on the other hand, increase
efficiency, but can generate severe quality problems due to
creaming (overtreating low-risk patients), skimping (redu-
cing quality in various ways, such as reducing LOS), or
dumping (avoiding the treatment of high-risk patients).
We have examined the level of the activity-based com-
ponent over a period of 8 years, and analysed how the
level correlates with LOS. To reduce the problem of
intradiagnostic heterogeneity in LOS, we limit the present
analysis to 3 ischemic heart diseases: angina pectoris, con-
gestive heart failure, and myocardial infarction. We
analysed our data with a log-linear regression model.
Institutional setting
The hospital sector in Norway is predominantly public
with only a few non-profit, private hospitals and some
for-profit hospitals that specialise in elective surgery. For
a general description of the Norwegian health care sys-
tem, see [17,18]. The hospital sector is organised into 4
regions that are each administered by a regional health
authority. The health regions are sub-divided in geo-
graphical catchment areas that are administered by
health enterprises. A health enterprise usually consists of
1–3 acute hospitals and several institutions that provide
addiction therapy and psychiatric services. Each health
region’s hospitals are organised hierarchically according
to functions and specialties with the regional, university
hospital at the top of the specialty hierarchy. Since July
1st 1997, Norwegian hospitals have had a mixed finan-
cing system consisting of a risk-adjusted capitation com-
ponent and an activity-based component. The nature of
the activity-based component depends on the number of
patients the institution treats, the patients’ DRGs, and
the national, standardised price per treatment. The
activity-based component has changed several times,
and constituted between 40% and 60% of expected hos-
pital revenues in the period from 2000 to 2007 (Figure 1).
The central government chooses the size of the activity-
based component after holding political discussions in
the parliament, so the size is exogenous to the different
hospitals in Norway. Finally, Norwegian hospital physi-
cians work on a salary basis [17].
Treatment of patients with heart diseases
The patients’ data were extracted from the Norwegian
Patient Register. These data include all individuals in
Norway who were suffering from at least one of 3 differ-
ent ischemic diagnoses at the time the data were origin-
ally collected.
Angina pectoris is temporary chest pain or a sensa-
tion of pressure on the chest that occurs when the
heart muscle is deprived of oxygen. It is caused by a
partially narrowed artery. Its treatment is typically de-
termined by the stability and the severity of the symp-
toms. When symptoms are stable and manifest mildly
or moderately, the common choice of treatment is medi-
cation and modification of risk factors (e.g., smoking).
When symptoms are unstable, immediate hospitalisation
is usually required so that doctors can closely monitor a
more intensive drug therapy and can consider the ne-
cessity of invasive procedures, such as percutaneous
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coronary intervention (PCI) or coronary artery bypass
grafting (CABG).
Myocardial infarction is usually a medical emergency
situation in which some of the heart’s blood supply is
suddenly and severely reduced or cut off, causing the
heart muscle (myocardium) to die because of oxygen
supply deprivation. Myocardial infarction is caused by a
totally blocked coronary artery, so it requires prompt
intervention. In addition to drug therapy, doctors often
elect to apply both PCI and CABG to patients with myo-
cardial infarction.
Congestive heart failure is generally defined as the
heart’s inability to supply sufficient blood flow to meet
the body’s needs. Myocardial infarction is one of the
most common causes of congestive heart failure. Treat-
ments of congestive heart failure vary to address the
various potential causes. Surgery is a valid treatment if
the cause of heart failure is a narrowed or leaking heart
valve or an abnormal connection between heart cham-
bers. Blockage or severe narrowing of a coronary artery
is likely to require drugs, surgery, or angioplasty. Heart
transplantation may also be an option for a few other-
wise healthy people who have not responded well to
traditional therapy.
Both PCI and CABG treatment in Norway are
centralised to specialised hospitals. PCI, which is the pro-
cedure most frequently used, is centralised to eight inter-
vention centres. For this reason, patients, especially
myocardial infarction patients who live in a catchment
area with only local hospitals, may first be admitted to a
local hospital and then transferred to an intervention
centre outside the catchment area. In such a case, they
would return to the local hospital before discharge. Since
our data are hospital-based and not episode-based, the
LOS for these patients might be separated into 2 or even
several parts. We discuss this problem later in this paper.
Methods
Data
The empirical analysis is based on repeated cross-
sectional data from 49 public hospitals and 4 private, non-
profit hospitals. Data were delivered by the Norwegian
Patient Register. The Department of Health Management
and Health Economics, University of Oslo applied and
received permission to use these data for this research
project. The data set includes the individual patient vari-
ables of age, sex, diagnoses, DRG weights, number of
comorbidities, admission type (non-elective or elective),
and LOS (in days). The study also complies with the
international and national ethical standards described by
The National Committee for Research Ethics in the So-
cial Sciences and the Humanities and by the Regional
Committees for Medical Research Ethics (REK). The ap-
proved individual data set for our empirical data analysis
is strictly confidential.
Defining catchment area groups
As indicated, the geographic location of PCI interven-
tion centres can influence patients’ LOS due to transfers.
Unfortunately, it is not possible to identify transfers be-
tween hospitals from our data. To amend this weakness,
we have defined 3 groups of hospital catchment areas
according to the likelihood of such transfers. Inclusion
of the group variables in the model serve as a proxy for
patient transfer data. The average LOS for the different
groups is shown in Figure 2. The first group (Group 1 in
Figure 2) consists of catchment areas where the inter-
vention centre is the only hospital. In this case, the
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Figure 2 Myocardial infarction patients’ LOS by catchment area group.
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patient, who is usually a patient with myocardial infarc-
tion, is likely to be fully treated within that single inter-
vention centre. The second group (Group 2 in Figure 2)
includes catchment areas with both intervention centres
and local hospitals, where some of the patients might
have received their entire treatment in a local hospital,
some in an intervention centre, and some across trans-
fers between an intervention centre and a local hos-
pital. The third group (Group 3 in Figure 2) consists
of catchment areas with only local hospitals that are
not intervention centres. In this group, a minority of
the patients were probably treated in full at the local
hospital, whereas the majority (e.g., myocardial infarction
patients) were more likely to be transferred between a
local hospital and an intervention centre in another
catchment area. As shown in Figure 2, Group 3 has the
shortest average LOS due to the high transfer rate.
Modelling the length of stay
Inspired by [12,19], we wrote our basic LOS function at
the individual level as:
yi ¼ x0iβþ αþ ui ð1Þ
where Yi is the logarithm of length of stay for admission
number i, x0i is a vector of exogenous variables, α is un-
observed individual effects, ui is an error term, and β is
a vector of coefficients.
According to the literature, longer LOS is associated
with older patients [20], females [12,21], patients with
more comorbidities [22], patients with a higher DRG
weight [22], patients with non-elective admission to the
hospital [21], and the incentives of the financing system
[11-13,23,24]. Furthermore, other time-related factors
can influence LOS, such as technology improvements,
development of outpatient care and nursing homes, and
patients’ preferences for short stays [23-25]. By gleaning
the literature and available data, we therefore included
the following explanatory variables in the empirical ana-
lysis: age, age square, gender (female = 1, male = 0), level
of ABF (the activity-based component), the DRG weight,
number of comorbidities, a patient admission dummy
(non-elective = 1, elective = 0), 2 dummies of ischemic
heart diagnosis (myocardial infarction = 0, angina
pectoris = 1, congestive heart failure = 1), 2 dummies
from the 3 catchment area groups (Group 1 = 1, Group
2 = 1, Group 3 = 0), and a linear time trend variable to
represent the influence of technological improvements
and other time-related factors. The DRG weights and
the number of comorbidities were included to account
for severe cases and cases of mixed severity, which can
influence resource use.
We estimated OLS regression of y on xi in equation 1. In
order to justify that the residuals are normally distributed,
we estimated the logarithm of LOS instead of LOS itself.
The coefficient β measures the effect of a change in regres-
sor xi on E(ln(LOS)|x). In order to investigate the possible
problems of heterogeneity, we also developed a pseudo-
panel model [26] by utilising Hausman-Taylor estimation
[27], and we describe this model and estimation in the
Appendix.
Results
Descriptive statistics
The original dataset includes 332,899 observations. Very
few patients (1,853 or 0.6%) stayed in the hospitals for
more than 30 days. Although some of these long-term
stays might represent actual hospital stays, we believe
that most of them are registration errors. We therefore
excluded these observations from the analysis, and thus
the final dataset includes 33,1046 observations. Table 1
shows the summary statistics by diagnoses and gender.
The average hospital LOS is 4.4 days (column 6, Table 1).
Females averaged a longer stay than did males (4.7 versus
4.3 days). The average patient age was 68.6 years, and fe-
males are about 7 years older than males (73.4 years ver-
sus 66.1 years). Thirty-eight percent of all patients that
we included in the study were diagnosed with myocardial
infarction, 25% with congestive heart failure, and 37%
with angina pectoris. About 73% of all patients were ad-
mitted non-electively, and 10% more females than males
were admitted non-electively. The patients also averaged
2 additional comorbidities, and females had more than
males did (2.1 versus 1.9). However, females had a lower
average DRG weight than did the males (1.2 versus 1.4).
Figure 3 shows the average LOS for all patients and
then separately for the 3 diagnoses. The downward
curves indicate that LOS reduced from 5.1 days in 2000
to 3.8 days in 2007 for the ischemic heart disease pa-
tient group as a whole, yet the reduction varies between
the 3 groups. The reduction in LOS for myocardial in-
farction and angina pectoris patients is probably an effect
of technological changes, in particular the introduction
of PCI.
Regression results
Table 2 displays the results from the log-linear regression
at the individual level. The coefficient of the activity-
based component is −0.129, which means that an in-
crease of 10 percentage points in the activity-based
component will reduce LOS by approximately 1.28%
(exp(−0.129*0.1) = 98.72%). The average LOS for women
was 1.9% longer than that for men. Larger effects were
obtained for the health-status measures; for example,
increasing the DRG weight by one unit increased LOS
by 26.5%, and increasing the number of comorbidities
by one prolonged LOS by 8.3%. The estimated effect of
being admitted electively compared to being admitted
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non-electively is a 38% rise in LOS. The LOS for angina
pectoris patients and congestive heart failure patients
was respectively 31.3% and 32.0% shorter than the LOS
for myocardial infarction patients (the reference dummy
variable) after controlling for other characteristics. The
effects of the catchment area groups are quite large and
significant, i.e., the LOS for patients staying in catch-
ment area group 1 and catchment area group 2 are re-
spectively 22.8% and 1.6% longer than the LOS for
patients in catchment area group 3. The coefficient of
the time trend is negative and significant. The non-
significance of age might be due to the fact that the
sample was restricted to elderly people, and our choice
of health-status measures might have emphasised the
health effects of age.
When we estimated the 3 diagnoses separately (shown
in columns 2–4), we found that increasing the activity-
based component significantly reduces LOS for myocar-
dial infarction patients. Myocardial infarction patients
also have the strongest negative time trend effects
among all 3 disease types. In contrast, increasing the
activity-based component has no effect on the LOS
of patients with congestive heart failure and/or an-
gina pectoris.
The pseudo-panel model in the Appendix displays re-
sults that are compatible with our individual-level analysis.
This model gave far less accurate estimates, however,
which is the reason why we primarily present the indi-
vidual level log-linear model results. Additionally, we
used a linear multilevel regression model and a negative
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Table 1 Descriptive statistics of ischemic heart diseases patients, based on the individual Norwegian patient register
dataset during 2000-2007
Ischemic heart diseases patients
Variables: Myocardial infarction Congestive heart failure Angina pectoris Male Female Total
Length of stay 5.72(4.77)1 3.43(3.49) 3.76(3.76) 4.27(4.09) 4.70(4.48) 4.42(4.23)
Age 70.59(13.86) 66.08(11.61) 68.21(12.59) 66.05(12.51) 73.36(12.47) 68.57(12.97)
Non-elective(%) 93(0.25) 43(0.49) 73(0.44) 69(0.46) 80(0.40) 73(0.44)
No. of Comorbidities 2.20(1.76) 2.03(1.44) 1.64(1.50) 1.86(1.57) 2.12(1.66) 1.95(1.61)
DRG weight2 1.41(0.99) 1.49(1.65) 1.22(1.44) 1.44(1.45) 1.20(1.15) 1.36(1.36)
Myocardial infarction(%) 37(0.48) 39(0.49) 38(0.48)
Congestive heart failure(%) 28(0.45) 20(0.40) 25(0.43)
Angina pectoris(%) 36(0.48) 40(0.49) 37(0.48)
Female(%) 36(0.48) 28(0.45) 37(0.48) 34(0.48)
Observations 124449 83307 123290 216953 114093 331046
1Std. Dev in the parentheses.
2Diagnosis-related group weight (DRG) is also called cost weight for a diagnosis related group, which expresses the related resource consumption of this patient
group compared to the average for all patient groups. (See the definition in the Norwegian Directorate of Health).
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binominal regression model. The results are similar in
magnitude and significance, as Table 2 indicates.
Discussion and conclusions
We have studied how the level of the activity-based
component in the hospitals’ financing system influences
the average length of hospital stays for elderly patients
suffering from ischemic heart diseases. The results show
that when the activity-based component increases by 10
percentage points, the average LOS of such elderly pa-
tients decreases by 1.28% or approximately 1.36 hours
(1.28%*4.42 days*24 hours). In other words, the hospitals
are responding to the economic incentive of an incre-
mental change in the activity-based component, but the
incentive’s ultimate impact on LOS is rather small.
We also found that other factors besides the activity-
based component are associated with longer LOS, in par-
ticular older patients, females, higher DRG weight, more
comorbidities, non-elective admission, and being diag-
nosed with myocardial infarction. These results are in ac-
cordance with findings from previous studies. The LOS
for patients who had stayed in catchment area group 1
and catchment area group 2 were longer than the LOS
for group 3, which verifies that the LOS for patients in
catchment area group 3 are likely to have been divided
due to the geographic location of the PCI centres. The
time trend variable, which is assumed to capture the
effects of technological progress, significantly reduces
LOS. Myocardial infarction patients have the strongest
negative time trend effects among the patient groups.
The myocardial infarction patients are recovering faster
in recent years due to the introduction of PCI treatment.
In the diagnosis-specific analyses, we discovered that
increasing the activity-based component significantly re-
duces LOS for myocardial infarction patients but not for
patients with congestive heart failure and angina pectoris.
This discrepancy might come from some other factors
that influence LOS among the latter 2 types of patients,
such as standardisation of practice, interdisciplinary team
dynamics, and physician leadership [28-32].
There has been much political debate regarding how
to reduce hospital costs. The conventional view is that
increasing the activity-based component results in a re-
duction in the length of patient stay and hence reduced
costs. Our results indicate that a reduction in the
activity-based component in the current high-powered
prospective payment system in Norway has only a small
impact on the reduction of LOS. Therefore, an incre-
mental change in the activity-based component does
not appear to give hospitals strong enough incentives to
reduce inpatient costs considerably for this specific pa-
tient group. The small effect observed in this analysis
might also have been caused by some hospitalisation
regulations and instructions for the treatment of these
Table 2 OLS regressions at the individual level
(1) (2) (3) (4)
All Myocardial infarction Congestive heart failure Angina pectoris
Age 0.001 (0.001) −0.002 (0.001) −0.002 (0.002) 0.014*** (0.001)
Age2/1000 0.050*** (0.007) 0.094*** (0.010) 0.077*** (0.014) −0.074*** (0.011)
Female 0.019*** (0.003) 0.048*** (0.005) −0.001 (0.005) 0.001 (0.004)
Activity-based component −0.129*** (0.017) −0.287*** (0.028) −0.041 (0.031) −0.039 (0.028)
DRG weight 0.265*** (0.003) 0.138*** (0.004) 0.275*** (0.004) 0.325*** (0.003)
No. of co morbidities 0.083*** (0.001) 0.102*** (0.001) 0.085*** (0.002) 0.064*** (0.002)
Non-elective 0.380*** (0.004) 0.508*** (0.009) 0.296*** (0.007) 0.515*** (0.006)
Angina pectoris1 −0.313*** (0.003)
Congestive heart failure −0.320*** (0.004)
Group123 0.228*** (0.004) 0.336*** (0.006) 0.190*** (0.010) 0.121*** (0.006)
Group24 0.016*** (0.004) 0.013* (0.006) 0.042*** (0.009) −0.012 (0.006)
Time trend −0.065*** (0.001) −0.100*** (0.001) −0.039*** (0.001) −0.039*** (0.001)
_cons 130.3*** (1.244) 201.6*** (2.082) 78.70*** (2.453) 77.66*** (1.956)
N 331046 124449 83307 123290
R2 0.322 0.243 0.360 0.289
Standard errors in parentheses.
*p < 0.05, ** p < 0.01, ***p < 0.001.
1Myocardial infarction is the reference dummy for both angina pectoris and congestive heart failure.
2Group 1 consists of catchment areas where the intervention center is the only hospital.
3Group 3 which consists of catchment areas with only local hospitals is the reference dummy for both Group 1 and Group 2.
4Group 2 consists of catchment areas with both intervention centers and local hospitals.
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3 ischemic heart diseases. For instance, these patients must
stay at the hospitals for a fixed amount of days to fulfil the
standard treatment plans for these diseases. On the other
hand, our results indicate that a higher activity-based com-
ponent is still generally recommendable, because it has a
positive effect on hospital activities in terms of number of
patients and hospital efficiencies [13,14,24]. Another factor
is that Norwegian physicians work on a salary basis and do
not receive pay according to the number of treated pa-
tients. They might not have the right economic incentives
to work directly to reduce the length of stay.
Our scope of interest in this paper has been restricted to
the effect of the activity-based component on LOS for eld-
erly patients suffering from heart diseases. One limitation
of the present study is that we focus only on patients with
these 3 ischemic heart diseases. Due to the treatment spe-
cialties for this patient group, the effects on LOS probably
differ for other patient groups, especially for diagnoses with
no prevailing treatment instructions. The other limitation
of this study is that we did not account for other factors
that might influence LOS while conducting our analyses,
such as waiting time, supply of beds, staffing ratios, pa-
tients’ rate of recovery, hospital and physician characteris-
tics [26,33], and specific indicators that reflect the severity
of illness for this patient group, e.g., the number of affected
vessels and the ejection fraction. It would be interesting to
explore how these factors impact LOS, as well. However, it
is reasonable to assume that there is no correlation be-
tween these factors and the activity-based component, so
we expect none of these factors to influence the activity-
based component’s effect on LOS.
Appendix
If the unobserved individual effects α are uncorrelated with
the explanatory variables in x′i in equation 1, we can get
the consistent and unbiased estimator by simply using
OLS in the repeated cross-sectional dataset. However, in
reality, the unobserved individual effects are likely to be
correlated with some or all of the explanatory variables,
which creates the unobserved heterogeneity problem. For
example, one patient might have more comorbidities than
other patients due to the severity of his or her diseases,
such as the number of affected vessels, ejection fraction,
etc. Therefore, OLS might lead to inconsistent estimators.
If we have genuine panel data, then we can easily solve this
problem by using the fixed effects model or the Hausman-
Taylor (HT) model [27] in equation 1. Unfortunately, we
had access to only repeated cross-section data, so we could
not follow the same individuals over time. This limitation
implies that the traditional panel approach cannot be used
directly in equation 1.
Deaton [26] suggested using the pseudo-panel technique
to perform panel estimation at the aggregated level. We
first had to group the individuals into pseudo-cohorts
based on a fixed membership that remained the same
throughout the entire period of observation. Here, we de-
fined each cohort C for every combination of single birth
year and gender. In order to make the cohort sizes fairly
equal across cohort groups, we merged the oldest and
youngest birth year for male and female patients separ-
ately (birth year < =1911 or > =1967 for males and birth
year < =1908 or > =1958 for females). Hence, each individ-
ual patient in the data set belongs to exactly one cohort.
This new data set is a pseudo-panel or a synthetic panel
with repeated observations over T periods and C cohorts.
It should also be noted that we reduced the number of
observations from 331,046 to 847 with this cohort group-
ing, indicating that the estimates from the pseudo-panel
method are less biased but suffer from less precision.
The aggregation of all observations to the cohort level
results in:
yct ¼ x0 ctβþ αc þ uct ð2Þ
where yct are the averages of all observed ln(LOS)’s in
cohort c at time period t, and similarly for the other var-
iables in the model. αc is the fixed cohort effects, which
Table 3 Hausman-Taylor estimation at the cohort level
HT
Age2/1000 0.150*** (0.019)
Female −0.046 (0.069)
Activity-based component −0.128*** (0.026)
DRG weight 0.308*** (0.019)
No. of comorbidities 0.068*** (0.014)
Non-elective 0.345*** (0.065)
Angina pectoris1 −0.083 (0.051)
Congestive heart failure −0.266*** (0.067)
Group123 0.061 (0.068)
Group24 −0.022 (0.057)
Time trend −0.069*** (0.003)
_cons 137.5*** (5.511)
N 864
Spec. Test56 χ29 ¼ 18:91
Standard errors in parentheses.
*p < 0.05, **p < 0.01, ***p < 0.001.
1Myocardial infarction is the reference dummy for both angina pectoris and
congestive heart failure.
2Group 1 consists of catchment areas where the intervention center is the
only hospital.
3Group 3 which consists of catchment areas with only local hospitals is the
reference dummy for both Group 1 and Group 2.
4Group 2 consists of catchment areas with both intervention centers and
local hospitals.
5We choose the exogenous variables X1 = (ABF, Group1, Group2, Year),
Z1 = (Female) to implement the HT estimator.
6Hausman’s test based on the difference between the within and HT estimator
gives an observed x29 ¼ 18:91. Compared to the Hausman’s test for fixed and
random effects which gives x210 ¼ 89:98, we can see that HT approach does
improve the efficiency in the fixed effects model.
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is correlated with x0ct (we assume αct ¼ αc in equation 2).
The dependent and the explanatory variables in equa-
tion 2 are weighted with the square root of the cohort
size before estimating, because the sample cohort means
should be the more reliable proxies for the population
cohort means when the corresponding cohort is large
[26]. We can then estimate equation 2 with the fixed ef-
fects model, and this model gives the within estimator
[26-31]. Even if the within estimator is a consistent and
unbiased estimator, it suffers from 2 significant defects
[34]. First, all time-invariant variables are eliminated by
the data transformation, so their coefficients cannot be
estimated (for example, the coefficient of female is re-
moved). Second, the within estimator is not fully effi-
cient, because it ignores the variation across individuals.
An IV estimator with neither of these defects was pro-
posed by [27]. The HT estimator exploits the assumption
that the explanatory variables are uncorrelated with the
fixed cohort effects. The HT model [27] can be written as:
yct ¼ x01ctβ1 þ x02ctβ2 þ z01cγ1 þ z02cγ2 þ αc þ uct
ð3Þ
Where x01ct and x02ct are vectors of time-varying vari-
ables, and z01c and z02c are vectors of time-invariant vari-
ables. In addition, x01ct and z01c are 2 vectors of
exogenous variables in that they do not correlate with αc
and uct , while x02ct and z02c are 2 endogenous variables
that correlate with αc but not with uct . Because x02ct and
z02c correlate with αc , estimating equation 3 by using the
random effects model does not result in consistent pa-
rameters. If we estimate equation 3 by using the fixed ef-
fects model, we are not estimating γ1 or γ2, because this
model eliminates z01c and z02c .
After using the Hausman specification test [33], we
chose the exogenous variables of x01ct ¼ ABF ;ð Group1;
Group2;YearÞ;z1c ¼ Femaleð Þ ,to implement the HT
estimator. In other words, we allowed some regressors
(i.e., age, comorbidities, non-elective, DRG weight, an-
gina pectoris, and congestive heart failure) to correlate
with the unobserved individual-level random effect. The
estimation results are presented in Table 3.
Moreover, when we compared log-linear regression at
the individual level (Table 2) with HT estimation at the
cohort level (Table 3), we revealed that the sign and the
size of the explanatory variables are similar except for
gender, angina pectoris, and 2 catchment area group var-
iables (group 1 and group 2). The 4 variables now turn
out to be insignificant, which reflects a trade-off between
estimate accuracy and estimate bias. The results at the
cohort level are less biased, but they lack the prize of
precision. As one can see by looking at Table 3, the con-
fidence intervals of the HT estimates are within the
confidence intervals of the log-linear estimates, and the
standard errors at the cohort level are larger than they
are at the individual level. This result is normal, because
the number of cohort groups is lower than the number
of individual observations. Therefore, we do not analyse
the data separately with 3 different diagnoses at the co-
hort level in order to prevent the standard errors that
are largely spread out at the cohort level. Our final re-
sults are based on a log-linear regression at the individ-
ual level (Table 2), because it is more precise.
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